The novel corona virus, Severe Acute Respiratory Syndrome Corona Virus 2 (SARS‐CoV‐2) is a deadly respiratory disease. The major causes of the rise of new variants of SARS-CoV-2 are genetic mutations and recombination. The club-shaped spike (S) projections of glycoprotein on the virus's envelope has interaction with the host cell’s ACE2 (Angiotensin-Converting Enzyme 2) receptors to enable the entrance of infectious virus particles. With-Corona’ is possible only when antiviral and vaccination are available. Disease prevention and control is based on new biosafety technologies and guidelines which improve ways to safely handle microbiological material. Corona pandemic is a serious biosafety event. Thus, biosafety is being valued worldwide and applied in medical field. This review presents the current biosafety standards of the COVID-19 pandemic in a comprehensive manner from a fragmented or wide variety of biosafety guidelines and articles available.
No takes yet. Share an insight, caveat, or question.
ALEMNEW et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: